Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71 (1994).
Article CAS PubMed Google Scholar
Hall, J. M. et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684–1689 (1990).
Article CAS PubMed Google Scholar
Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789–792 (1995).
Article CAS PubMed Google Scholar
Moslehi, R. et al. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am. J. Hum.Genet. 66, 1259–1272 (2000).
Article CAS PubMed PubMed Central Google Scholar
Kuchenbaecker, K. B. et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. J. Am. Med. Assoc. 317, 2402–2416 (2017).
Foulkes, W. D. The ten genes for breast (and ovarian) cancer susceptibility. Nat. Rev. Clin. Oncol. 18, 259–260 (2021).
Article CAS PubMed Google Scholar
Pharoah, P. D. et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet. 31, 33–36 (2002).
Article CAS PubMed Google Scholar
Tutt, A. N. J. et al. Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer. N. Engl. J. Med. 384, 2394–2405 (2021).
Article CAS PubMed PubMed Central Google Scholar
Manickam, K. et al. Exome sequencing-based screening for BRCA1/2 expected pathogenic variants among adult biobank participants. JAMA Netw. Open 1, e182140 (2018).
Article PubMed PubMed Central Google Scholar
Hughley, R. et al. Etiologic index - a case-only measure of BRCA1/2-associated cancer risk. N. Engl. J. Med. 383, 286–288 (2020).
留言 (0)